Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MILNACIPRAN vs MILTEFOSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MILNACIPRAN vs MILTEFOSINE: Safety Overview

Metric MILNACIPRAN MILTEFOSINE
Total FAERS Reports 1,392 242
Deaths Reported 120 82
Death Rate 8.6% 33.9%
Hospitalizations 274 76
Average Patient Age 54.8 yrs 48.3 yrs
% Female Patients 82.6% 34.4%
FDA Approval Date Apr 22, 2016 Mar 19, 2014
Manufacturer Cardinal Health 107, LLC Profounda, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription